CM/PHR/23/5702 - NHS National Framework for Tocilizumab - March 2024

Award

Buyers

2182135

Value

£46,600,000

Suppliers

Classifications

Pharmaceutical products

Submission Deadline

1 year ago

Published

1 year ago

Description

Project Title: NHS National Framework for Tocilizumab - March 2024

Offer reference number: CM/PHR/23/5702

CM/PHR/23/5702/01 NHS Framework for Tocilizumab LONDON and SOUTH OF ENGLAND. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/23/5702/02 NHS Framework for Tocilizumab NORTH OF ENGLAND and MIDLANDS AND EAST. Period of framework: 1 March 2024 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Documents

Premium

Bypass the hassle of outdated portals. Get all the information you need right here, right now.

Contract Agreement

The official contract terms, conditions, and scopes of work.

Download
Award Notice

Details on the tender award and selected suppliers.

Download